Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RXRX Recursion Pharmaceuticals, Inc.

Pre-Mkt 06-02 04:48:02 EDT

3.79

+0.20

+5.57%

盘前3.75

-0.04-1.06%

04:46 EDT

High3.85	Low3.45	Vol30.99M
Open3.53	D1 Closing3.59	Amplitude11.14%
Mkt Cap2.00B	Tradable Cap1.57B	Total Shares527.40M
T/O113.67M	T/O Rate7.47%	Tradable Shares415.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.79,"timestamp":1780344000000,"preClose":3.59,"halted":0,"volume":30989115,"hourTrading":{"tag":"盘前","latestPrice":3.75,"preClose":3.79,"latestTime":"04:46 EDT","volume":29401,"amount":109578.9294277,"timestamp":1780390014107,"change":-0.04,"changeRate":-0.010554,"amplitude":0.01847},"delay":0,"changeRate":0.05571030640668529,"floatShares":415000000,"shares":527397997,"eps":-1.168441,"marketStatus":"Pre-Mkt","change":0.2,"latestTime":"06-02 04:48:02 EDT","open":3.53,"high":3.85,"low":3.45,"amount":113668736.98706101,"amplitude":0.111421,"askPrice":3.75,"askSize":352,"bidPrice":3.7,"bidSize":122,"shortable":3,"etf":0,"ttmEps":-1.168441,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780407000000},"marketStatusCode":1,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":3.79,"preHourTrading":{"tag":"盘前","latestPrice":3.75,"preClose":3.79,"latestTime":"04:46 EDT","volume":29401,"amount":109578.9294277,"timestamp":1780390014107,"change":-0.04,"changeRate":-0.010554,"amplitude":0.01847},"postHourTrading":{"tag":"盘后","latestPrice":3.7899,"preClose":3.79,"latestTime":"19:59 EDT","volume":607579,"amount":2298967.6865,"timestamp":1780358357742,"change":-0.0001,"changeRate":-0.000026,"amplitude":0.013193},"volumeRatio":1.2414204341593484,"optionData":{"bulkOrders":[{"symbol":"RXRX","call":true,"expireDate":1781755200000,"strike":"7.0","timestamp":1780337112634,"price":0.03,"volume":1588,"amount":4764,"type":"*"}]},"impliedVol":0.6608,"impliedVolPercentile":0.072},"requestUrl":"/m/hq/s/RXRX/","defaultTab":"news","newsList":[{"id":"2639563677","title":"Recursion grants inducement RSUs covering 2,991,840 shares to 33 new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2639563677","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639563677?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:31","pubTimestamp":1780086668,"startTime":"0","endTime":"0","summary":"Recursion set inducement restricted stock unit awards covering 2,991,840 Class A shares for 33 new employees under its 2024 Inducement Equity Incentive Plan.Awards vest 25% on the first quarterly vesting date on or following the one-year anniversary of the vesting start date.Remaining shares vest 6.25% each quarter until fully vested, subject to continued employment through vesting dates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL79NTzz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4548","BK4139","BK4539","BK4609","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677317","title":"Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677317?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:30","pubTimestamp":1780086600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA1KGWGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4611","BK4548","RXRX","BK4609","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638635763","title":"Recursion Pharmaceuticals director Christopher Gibson disposes of 40,000 common shares for $ 123,200","url":"https://stock-news.laohu8.com/highlight/detail?id=2638635763","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638635763?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:16","pubTimestamp":1779912983,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals director Christopher Gibson sold 40,000 Class A common shares on May 22 at USD 3.08.He ended the day with 883,735 Class A shares, following a same-day 40,000-share Class B-to-Class A conversion at USD 0.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLw8dBx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharmaceuticals director Christopher Gibson disposes of 40,000 common shares for $ 123,200","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4539","BK4548","BK4609","RXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376853","title":"Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Lose Momentum In Recent Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376853","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637376853?lang=en_us&edition=fundamental","pubTime":"2026-05-24 04:18","pubTimestamp":1779567493,"startTime":"0","endTime":"0","summary":"Recent performance snapshot\nRecursion Pharmaceuticals (RXRX) has drawn investor attention after its share price closed at US$3.01, with the stock down about 19% over the past month and roughly 12% over the past 3 months.\nSee our latest analysis for Recursion Pharmaceuticals.\nFor context, RXRX’s 1-day share price return declined 3.22%, and the 30-day share price return is down 19.30%, while the 1-year total shareholder return has fallen 26.23%. This points to fading momentum after earlier...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/assessing-recursion-pharmaceuticals-rxrx-valuation-as-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/assessing-recursion-pharmaceuticals-rxrx-valuation-as-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4609","BK4548","BK4539","BK4139","RXRX","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192475061","title":"Nvidia-Linked Shares Rally.  Applied Digital up 18%; NEBIUS up 17%; WhiteFiber up 13%; ARM Holdings, Lumentum up 9% Each; CoreWeave up Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192475061","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192475061?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:46","pubTimestamp":1779374798,"startTime":"0","endTime":"0","summary":"Nvidia-linked shares rallied on Thursday. Applied Digital up 18%; NEBIUS up 17%; WhiteFiber up 13%; ARM Holdings up over 9%; CoreWeave up nearly 5%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5620f63221950ec81cf79f6825aaef2b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOUN","NVII","ARM","NVDO","MUU","ANV","NVDU","NVDA","NEBX","ARMW","CRNC","MUD","APLX","NVD","NVDS","APLD","NVDX","RXRX","NVDD","APLZ","NBIL","NVDG","NVYY","INVZ","SERV","NBIS","07788","TM","ARMG","DIPS","NBIZ","MU","07388","ARBE","NNOX","AUR","MULL","NVDL","NVDW","NVDB","ARMU","NVDQ","NVDY","SOUX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635742691","title":"Recursion Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635742691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635742691?lang=en_us&edition=fundamental","pubTime":"2026-05-15 01:34","pubTimestamp":1778780040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 13:34 ET (17:34 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4548","RXRX","BK4139","BK4609","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112758563","title":"Stock Track | Recursion Pharmaceuticals Soars 5.08% Intraday After Morgan Stanley Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1112758563","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112758563?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:34","pubTimestamp":1778765658,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc. (RXRX) saw its stock price soar 5.08% during intraday trading on Thursday, reflecting a significant positive movement in its share value.The surge appears to be driven...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635093719","title":"Morgan Stanley Raises Price Target on Recursion Pharmaceuticals to $5.50 From $5, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635093719","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635093719?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:07","pubTimestamp":1778756827,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (RXRX) has an average rating of overweight and mean price target of $6.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","RXRX","BK4139","BK4609","BK4539","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467320","title":"Recursion director Christopher Gibson disposes of 60,000 shares for $134,800","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467320","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467320?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:00","pubTimestamp":1778274002,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals director Christopher Gibson reported sales of 40,000 Class A common shares at USD 3.37 on May 7, 2026.He also reported a gift of 20,000 Class A common shares.He acquired 60,000 Class A common shares at USD 0, lifting direct holdings to 966,556 shares before reported dispositions reduced that figure to 906,556 shares.Filing flagged transactions under a Rule 10b5-1 trading plan adopted May 12, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL7zvJd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion director Christopher Gibson disposes of 60,000 shares for $134,800","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","BK4611","BK4609","BK4539","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633099172","title":"Recursion director Blake Borgeson disposes 30,000 shares for $105,600","url":"https://stock-news.laohu8.com/highlight/detail?id=2633099172","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633099172?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:53","pubTimestamp":1778187215,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on May 5 at USD 3.52.Direct holdings fell to 6,199,863 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL480PDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion director Blake Borgeson disposes 30,000 shares for $105,600","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4609","BK4611","BK4548","RXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142370","title":"Recursion Pharmaceuticals Price Target Maintained With a $8.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142370?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:13","pubTimestamp":1778155980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 07, 2026 08:13 ET (12:13 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RXRX","BK4548","BK4609","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633936148","title":"Recursion Pharmaceuticals (RXRX) Receives a Hold from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2633936148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633936148?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:37","pubTimestamp":1778150278,"startTime":"0","endTime":"0","summary":"In a report released today, Alec Stranahan from Bank of America Securities reiterated a Hold rating on Recursion Pharmaceuticals, with a price targ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-receives-a-hold-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/recursion-pharmaceuticals-rxrx-receives-a-hold-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1363072403.SGD","LU0130517989.USD","LU0321505868.SGD","LU0787776722.HKD","BK4534","LU1201861165.SGD","BK4588","LU0648001328.SGD","LU0477156953.USD","LU0256863811.USD","IE0002270589.USD","BK4539","IE00BBT3K403.USD","LU2129689514.USD","LU0052756011.USD","BK4207","LU0683600562.USD","LU0477156797.USD","BK4611","LU0203345920.USD","LU0098860793.USD","LU0234572021.USD","LU0256863902.USD","LU0868494617.USD","LU0203347892.USD","BK4553","IE00B19Z3B42.SGD","BK4585","IE00B7SZLL34.SGD","BK4139","LU1894683348.USD","LU1668664300.SGD","LU1880398554.USD","LU0306807586.USD","LU0170899867.USD","LU1791807156.HKD","LU0310800965.SGD","LU1883839398.USD","IE00BLSP4239.USD","IE0001KFT4U8.USD","LU0314106906.USD","LU0640476718.USD","LU0980610538.SGD","BK4609","LU2129689431.USD","IE00B1BXHZ80.USD","LU0211331839.USD","LU2133065610.SGD","LU2129689605.HKD","LU0106831901.USD","IE00BKVL7J92.USD","LU1366192091.USD","LU1069347547.HKD","LU1267930227.SGD","LU0648000940.SGD","BK4581","LU0321505439.SGD","LU1880398471.USD","IE00BZ1G4Q59.USD","LU1201861249.SGD","IE0034235188.USD","LU0417517546.SGD","LU0130102774.USD","IE00BFXG1179.USD","BK4548","IE00BLSP4452.SGD","LU2265009873.SGD","LU0320765489.SGD","BK4559","LU1496350502.SGD","LU1162221912.USD","LU0130103400.USD","LU1035773651.USD","LU1074936037.SGD","LU1718418525.SGD","LU0234570918.USD","LU0053666078.USD","IE00B19Z3581.USD","LU1506573853.SGD","LU1804176565.USD","LU0149725797.USD","BK4582","LU0306806265.USD","LU1280957306.USD","LU0128525689.USD","BK4504","LU0320765646.SGD","LU0971096721.USD","LU0130518102.USD","LU1496350171.SGD","LU0208291251.USD","LU0070302665.USD","RXRX","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633897110","title":"Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633897110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633897110?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:20","pubTimestamp":1778149246,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kissei Pharmaceutical Co (KSPHF), Recursion Pharmace...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kissei-pharmaceutical-co-otherksphf-recursion-pharmaceuticals-rxrx-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kissei-pharmaceutical-co-otherksphf-recursion-pharmaceuticals-rxrx-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","BK4581","BK4611","LU0128526141.USD","BK4007","ACAD","BK4588","LU2065171402.SGD","BK4585","RXRX","BK4609","XBI","KSPHF","BK4539","LABU","LU0029874061.USD","LU2065170008.USD","LU2065171311.SGD","BK4137","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633415968","title":"Wall Street Analysts Are Neutral on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2633415968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633415968?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:00","pubTimestamp":1778097630,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Geron (GERN) and Recursion Pharmaceuticals (RXRX) with neutral ratings, indicating that the experts a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-healthcare-picks-blurbs-news-9?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-healthcare-picks-blurbs-news-9?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4611","RXRX","LU0128526141.USD","GERN","BK4137","BK4588","BK4548","BK4139","BK4581","BK4585","LU0029874061.USD","LABU","BK4609","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633136448","title":"BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber","url":"https://stock-news.laohu8.com/highlight/detail?id=2633136448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633136448?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:24","pubTimestamp":1778073888,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, UberWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:/","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL6N41J0N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBER","SMCL","COR","ETR","AMD","XOM","AVTX","COP","OSCG","SMCI","DIS","MNKD","LCID","COTY","LINT","NVDY","SMCY","NVAX","MASS","BCRX","ELAN","INGM","LUMN","GLW","UTHR","NVDB","CVX","ARM","DECK","QCOM","CMI","NVDQ","OSCR","ANET","NYT","NVDA","KHC","CVS","ORKA","INTC","NVII","AMDS","FRPT","RSI","HUT","AMCR","OXY","APO","RXRX","PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633336180","title":"BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor","url":"https://stock-news.laohu8.com/highlight/detail?id=2633336180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633336180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:39","pubTimestamp":1778067553,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers OutdoorWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL6N41J0OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","LU2498475776.HKD","LU0823434740.USD","LU2430703095.HKD","LU0823421416.USD","LU0320765489.SGD","LU2129689514.USD","BK4162","BK4600","DAMD","BK4135","BK4534","BK4089","LU0795875169.SGD","LU1116320901.HKD","LU1150488218.USD","SG9999015952.SGD","SMCZ","COTY","LU1699723380.USD","LU0859254822.USD","LU0345770308.USD","LU0079474960.USD","LU0466842654.USD","LU1506573853.SGD","LU0278409577.USD","BK4146","IE0009356076.USD","BK4550","LU0256331488.USD","LU0979878070.USD","LU1280957306.USD","LU1064131342.USD","LU2168564495.EUR","LU1674673428.USD","LU2360032135.SGD","XOMX","BK4548","INTW","LU2148611432.USD","DIS","IE0034235303.USD","IE0002270589.USD","LU0266013472.USD","SG9999002224.SGD","LU0823434583.USD","BK4532","CVX","XOMZ","BK4575","ARM","OSCX","BK4139","LU0320765646.SGD","LU1261432733.SGD","LU1951200564.SGD","LU1585245621.USD","LU1929549753.HKD","SMYY","LU0082616367.USD","LU1069347547.HKD","CVS","LU2125154935.USD","SG9999002232.USD","LU0098860793.USD","SG9999014575.USD","IE00B7SZLL34.SGD","IE00BMPRXR70.SGD","LU1983299246.USD","LU1815333072.USD","LU2168564222.USD","LU0345780950.USD","LU0130103400.USD","LU2054465674.USD","LU2286300806.USD","IE000M9KFDE8.USD","LU1861219969.SGD","LU1861215975.USD","LU0210533765.USD","LU0265550359.USD","LU1814569148.SGD","LU0552385451.USD","BK4533","TSM","LU0648001328.SGD","LU0612318971.USD","BK4023","LU0128525929.USD","LU1880398554.USD","LU2505996681.GBP","SMCX","BK4084","LU0642271901.SGD","LU2097829019.USD","AMUU","LU0321505439.SGD","LU0211327993.USD","LU0345781412.USD","ARMW","LU2102340556.USD","LU0868494617.USD","LU2357305700.SGD","LU0654597011.USD","BK4503","LU1861558580.USD","ANET","LU0266512127.USD","LU2360106780.USD","LU1069344957.HKD","LU0265550946.USD","BK4596","LU2505996509.AUD","LU0726765562.USD","LU1035775433.USD","LU0310799852.SGD","AMDU","ARMU","BK4141","BK4543","LU1066051498.USD","LU2355687059.USD","LU1861559042.SGD","LU2458330169.SGD","LCIZ","LU1548497426.USD","BK4551","BK4581","IE00B3CCJ963.GBP","LU1119994496.HKD","LU1720051108.HKD","BK4539","BK4516","IE00BMPRXN33.USD","LU0980610538.SGD","LU0170899867.USD","LU1668664300.SGD","INGM","BK4555","LU2089985449.USD","LU0289739699.SGD","LU1988902786.USD","BK4140","LU1162221912.USD","BK4536","LU2087621335.USD","LU0912757837.SGD","BK4612","LU1267930813.SGD","APO","BK4614","SG9999001440.SGD","LU0203347892.USD","LU1430597077.USD","LU1941712264.USD","SGXZ31699556.SGD","LU0417517546.SGD","LU1732799900.SGD","LU2324357040.USD","LU1894683348.USD","LU1720051017.SGD","LU0056508442.USD","LCDL","SG9999015358.SGD","IE00B2Q91V27.USD","LU0070217475.USD","LU0823421333.USD","LU0225283273.USD","LU2247934214.USD","SG9999014914.USD","LU1244550494.USD","LU0203345920.USD","LU0154245756.USD","LU1989764664.SGD","IE00B775SV38.USD","IE00B19Z3581.USD","LU2999663052.SGD","LU2098885051.SGD","SG9999014567.USD","BK4559","IE00BGHQDM52.EUR","XOM","LU1582986359.USD","BK4515","LU0048573561.USD","LU1201861249.SGD","BK4602","LU0985489474.SGD","SG9999015978.USD","IE00BZ199S13.USD","BK4007","BK4535","BK4170","SG9999015986.USD","IE00BFMHRM44.USD","LU2360107325.USD","QCOM","LU2931357623.SGD","LU0557290698.USD","LU2129689605.HKD","IE00BWXC8680.SGD","LU1983260115.SGD","LU0210528500.USD","COP","IE00BN0W2V16.EUR","LU2129689431.USD","LU2347655073.USD","SG9999001424.SGD","BK4183","LU0061475181.USD","BK4604","LU1201861165.SGD","LU0368265418.SGD","BK4108","LU0742534661.SGD","LU0310800379.SGD","BK4022","LU0251131958.USD","LU0786609619.USD","04335","AMYY","BK4598","LU0345770993.USD","LU0266512473.USD","LU1046421795.USD","LU1571399168.USD","LU0708994859.HKD","BK4609","LINT","BK4595","LU1582986433.USD","GB00BDT5M118.USD","SGXZ81514606.USD","LU0143551892.USD","LU0274383776.USD","LU2168563687.JPY","BK4213","LU0162691827.USD","SG9999004303.SGD","LU0878866978.SGD","LU1242518857.USD","LU1861220033.SGD","LU0868494708.USD","LU1894683264.USD","LU0787776722.HKD","LU2108987350.USD","IE00BVYPNQ40.USD","LU0256863811.USD","BK4579","LU2133065610.SGD","LU1244550221.USD","HUTG","LU0061474960.USD","LU0070302665.USD","BK4149","COR","LU2357627491.SGD","BK4512","INTC","SMCL","IE00BVYPNP33.GBP","LU1803068979.SGD","LU0612318385.USD","AVTX","IE00BKDWB100.SGD","LU0029864427.USD","LU0107464264.USD","HUT","MASS","BK4529","LU2106854487.HKD","LU0211328371.USD","LU0630314457.HKD","SG9999018865.SGD","LU1430594728.SGD","LU1852331112.SGD","LU1917777945.USD","SG9999014906.USD","LU1778281490.HKD","BK4196","BK4184","IE00B5949003.HKD","LU0300736062.USD","BK4507","LU0130102774.USD","LU0788109394.HKD","LU1489326972.SGD","BK4505","LU0058720904.USD","LU0353189680.USD","LU0068578508.USD","LU2168564149.EUR","LU2458330243.SGD","BK4573","ARMG","SG9999014542.SGD","SMCI","LU1496350502.SGD","XOMO","LU2087625088.SGD","LU2023250504.SGD","LUMN","LU0456854461.SGD","LU0300736492.USD","IE00B1XK9C88.USD","LU0211331839.USD","QCML","LU2347655156.SGD","BK4099","LU0106261372.USD","BK4585","LU1951198990.SGD","LU1242518931.SGD","SGXZ51526630.SGD","LU0109392836.USD","BK4605","OSCG","IE00BSNM7G36.USD","BK4527","LU0719512351.SGD","LU0234572021.USD","LU1084165304.USD","LU1974910355.USD","SG9999015341.SGD","LU0432979614.USD","LU1059921491.USD","IE00BN0W2W23.USD","LU0795875086.SGD","LU0081259029.USD","LU1035773651.USD","LU1823568750.SGD","BK4567","LU0321505868.SGD","LU0149725797.USD","SG9999002521.SGD","LU2487616109.SGD","LU2125154778.USD","LU0683600562.USD","LU0353189763.USD","IE0008368304.USD","LU0251142724.SGD","LU0208291251.USD","LU2954938101.SGD","LU0433182093.SGD","LU1496350171.SGD","LU1582987324.SGD","QCMU","BK4561","LU0314106906.USD","LU1267930573.SGD","LU1941712348.USD","BK4230","BK4592","UBEW","LU1674673691.USD","LU1880398471.USD","UBRL","IE0004445239.USD","LU0477156953.USD","LU1116320737.USD","IE00BN0W2T93.GBP","LU0648000940.SGD","BK4201","UBER","LU0077335932.USD","SGXZ23171101.USD","LU0390134368.USD","IE00BKVL7J92.USD","BK4524","IE00B3S45H60.SGD","LU1316542783.SGD","LU0122376428.USD","DISO","LU1883866441.USD","SG9999000418.SGD","LU2462591277.SGD","LU0640476718.USD","ELAN","LU2860962120.EUR","RXRX","SMCY","LU0198837287.USD","OSCR","SG9999014559.SGD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU1323610961.USD","BK4504","LU1074936037.SGD","LU1861214812.USD","AMDS","LU2592432038.USD","LU0154245673.USD","LU0238689110.USD","LU0957791311.USD","LU1923623000.USD","QCMD","LU0889566641.SGD","LU2168564065.EUR","DECK","SGXZ99366536.SGD","BK4584","LU0889565833.HKD","SG9999018857.SGD","AMDW","LU2237438978.USD","IE00BFXG1179.USD","LU2237957902.USD","LU1791807156.HKD","LU1267930490.SGD","AMDL","IE00BMPRXQ63.HKD","LU2462611646.USD","LU0348723411.USD","LU2250418816.HKD","LU1582987597.SGD","BK4554","IE00BGHQF524.EUR","LU0792757196.USD","LU0053671581.USD","AMDY","AMDG","LU2602419157.SGD","LU0072461881.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0053666078.USD","CMI","LU0127658192.USD","LU2543165471.USD","SG9999017495.SGD","AMDD","BK4570","LU2237957811.SGD","IE00B1BXHZ80.USD","LU2430703251.USD","BK4566","OXY","LCID","LU0011850046.USD","LU0006061336.USD","LU0006306889.USD","LU0130517989.USD","BK4157","LU2264538146.SGD","LU1150488135.SGD","LU2211815571.USD","SMCC","LU1718418525.SGD","LU1839511570.USD","SG9999014898.SGD","SG9999015945.SGD","LU0097036916.USD","LU0942090050.USD","BK4020","BK4611","LU0106831901.USD","SG9999014880.SGD","BK4175","BK4588","AMD","LU1303367103.USD","LU1732800096.USD","LU2381873111.SGD","LU2430703178.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633184946","title":"BUZZ-Recursion falls after quarterly revenue miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2633184946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633184946?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:57","pubTimestamp":1778065039,"startTime":"0","endTime":"0","summary":"BUZZ-Recursion falls after quarterly revenue miss** Shares of drug developer Recursion Pharmaceuticals RXRX.O fall 3.9% to $3.25 premarket** Co's Q1 revenue of $6.5 million misses analysts' average expectation of $15.8 million - LSEG data** RXRX says total revenue primarily consists of revenue from collaboration agreements ** Says Roche ROPC.S collaboration revenue recognized was less in the current period due to the successful completion of certain project phases in the prior period** Up to last close, stock was down 17.6% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL4N41J13D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4548","BK4611","BK4139","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181243","title":"Recursion Pharmaceuticals Shares Dip 3% Premarket After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633181243?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:46","pubTimestamp":1778064374,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL4N41J12K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","RXRX","BK4539","BK4611","BK4139","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181190","title":"Recursion Pharmaceuticals misses Q1 operating revenue estimates, net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181190","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633181190?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:43","pubTimestamp":1778064207,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals missesQ1 operating revenue estimates, net loss narrowsOverviewUS drug discovery firm's Q1 operating revenue missed analyst expectationsQ1 net loss narrowed, helped by lower R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL1N41J0GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","RXRX","BK4139","BK4611","BK4539","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633189446","title":"Recursion Pharmaceuticals Q1 EPS $(0.22) Beats $(0.27) Estimate, Sales $6.472M Miss $15.777M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633189446","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633189446?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:31","pubTimestamp":1778063499,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.27) by 18.52 percent. This is a 56 percent increase over losses of $(0.50) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52314496/recursion-pharmaceuticals-q1-eps-0-22-beats-0-27-estimate-sales-6-472m-miss-15-777m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4539","BK4611","BK4609","RXRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":0.2591},{"period":"1month","weight":0.118},{"period":"3month","weight":0.0706},{"period":"6month","weight":-0.1867},{"period":"1year","weight":-0.0933},{"period":"ytd","weight":-0.0733}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.287},{"period":"ytd","weight":0.1124}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 1b/2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer; REC-64151 for the treatment of immune checkpoint resistance; and Anti-PD-(L)1, an orally bioavailable small molecule to improve sensitivity to immune checkpoint inhibitors in non-small cell lung cancer and additional tumors. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.049361},{"month":3,"riseRate":0,"avgChangeRate":-0.249219},{"month":4,"riseRate":0.4,"avgChangeRate":-0.090167},{"month":5,"riseRate":0.5,"avgChangeRate":0.076509},{"month":6,"riseRate":0.666667,"avgChangeRate":0.12309},{"month":7,"riseRate":0.8,"avgChangeRate":0.206054},{"month":8,"riseRate":0.2,"avgChangeRate":-0.126569},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050486},{"month":10,"riseRate":0.2,"avgChangeRate":-0.079168},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}